A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

BACKGROUND: Asymmetric dimethylarginine (ADMA) is a competitive inhibitor of endothelial nitric oxide synthase (eNOS) that is associated with endothelial dysfunction, and is a risk marker for cardiovascular disease, a significant problem in Type 1 diabetes. The aim of the present study was to measur...

Full description

Saved in:
Bibliographic Details
Main Authors: Sibal, Latika, Agarwal, Sharad C, Schwedhelm, Edzard, Lüneburg, Nicole, Böger, Rainer H, Home, Philip D
Format: Artigo
Language:Inglês
Published: BioMed Central 2009
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2698883/
https://ncbi.nlm.nih.gov/pubmed/19486510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2840-8-27
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items